101 related articles for article (PubMed ID: 16562646)
1. [Immune evasion mechanisms of hepatitis C virus. Review].
Porto-Espinoza L; Cuadra-Sánchez C; Moronta R; Monsalve-Castillo F; Callejas-Valero D
Invest Clin; 2006 Mar; 47(1):71-82. PubMed ID: 16562646
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus--T-cell responses and viral escape mutations.
Petrovic D; Dempsey E; Doherty DG; Kelleher D; Long A
Eur J Immunol; 2012 Jan; 42(1):17-26. PubMed ID: 22125159
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus and the immune system: a concise review.
Gremion C; Cerny A
Rev Med Virol; 2005; 15(4):235-68. PubMed ID: 15782389
[TBL] [Abstract][Full Text] [Related]
4. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
Moorman JP; Joo M; Hahn YS
Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
[TBL] [Abstract][Full Text] [Related]
5. HCV immunopathogenesis: virus-induced strategies against host immunity.
Szabo G; Dolganiuc A
Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
7. Viral hepatitis and liver cancer: the case of hepatitis C.
Levrero M
Oncogene; 2006 Jun; 25(27):3834-47. PubMed ID: 16799625
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Bode JG; Brenndörfer ED; Häussinger D
Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
[TBL] [Abstract][Full Text] [Related]
9. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
10. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
Hiroishi K; Ito T; Imawari M
J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of HCV-mediated immune dysregulation.
Eisen-Vandervelde AL; Yao ZQ; Hahn YS
Clin Immunol; 2004 Apr; 111(1):16-21. PubMed ID: 15093547
[TBL] [Abstract][Full Text] [Related]
12. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.
Schvoerer E; Soulier E; Royer C; Renaudin AC; Thumann C; Fafi-Kremer S; Brignon N; Doridot S; Meyer N; Pinson P; Ellero B; Woehl-Jaegle ML; Meyer C; Wolf P; Zachary P; Baumert T; Stoll-Keller F
J Infect Dis; 2007 Aug; 196(4):528-36. PubMed ID: 17624837
[TBL] [Abstract][Full Text] [Related]
13. Virology and pathogenesis of hepatitis C virus recurrence.
Ramírez S; Pérez-Del-Pulgar S; Forns X
Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
[TBL] [Abstract][Full Text] [Related]
14. [Immunology of hepatitis C: clinical significance of T cell response].
Shin EC
Korean J Hepatol; 2006 Jun; 12(2):140-53. PubMed ID: 16804339
[TBL] [Abstract][Full Text] [Related]
15. Natural history of hepatitis C virus infection.
Mondelli MU
J Biol Regul Homeost Agents; 2003; 17(2):128-32. PubMed ID: 14518710
[TBL] [Abstract][Full Text] [Related]
16. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
Gaudieri S; Rauch A; Park LP; Freitas E; Herrmann S; Jeffrey G; Cheng W; Pfafferott K; Naidoo K; Chapman R; Battegay M; Weber R; Telenti A; Furrer H; James I; Lucas M; Mallal SA
J Virol; 2006 Nov; 80(22):11094-104. PubMed ID: 17071929
[TBL] [Abstract][Full Text] [Related]
17. A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation.
Hanada K; Tanaka Y; Mizokami M; Gojobori T; Alter HJ
Virology; 2007 Apr; 361(1):27-33. PubMed ID: 17174372
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
19. Host factors involved in the replication of hepatitis C virus.
Moriishi K; Matsuura Y
Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
[TBL] [Abstract][Full Text] [Related]
20. Prospects for hepatitis C vaccine.
Bhopale GM; Nanda RK
Acta Virol; 2004; 48(4):215-21. PubMed ID: 15745044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
